Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × ficlatuzumab × Thoracic × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 132 Pemetrexed 113 Cisplatin 99 pembrolizumab 85 Docetaxel 82 Paclitaxel 78 Erlotinib Hydrochloride 54 Radiotherapy 52 Nivolumab 46 Gemcitabine 45 Bevacizumab 39 Etoposide 35 Radiosurgery 29 atezolizumab 27 durvalumab 24 Cyclophosphamide 21 Vinorelbine 18 Radiation 18 Ipilimumab 16 Taxes 15 Albumin-Bound Paclitaxel 14 Drug Therapy 13 130-nm albumin-bound paclitaxel 13 Magnetic Resonance Spectroscopy 12 Irinotecan 12 Gefitinib 12 Dexamethasone 12 avelumab 11 osimertinib 10 Vorinostat 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02318368 2020-10-22

FOCAL

AVEO Pharmaceuticals, Inc.

Phase 2 Terminated

10 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡